CuraScientific Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, sales was USD 1.05 million compared to USD 0.034434 million a year ago. Net income was USD 35.35 million compared to net loss of USD 3.61 million a year ago. Basic earnings per share from continuing operations was USD 0.12 compared to basic loss per share from continuing operations of USD 0.89 a year ago. Diluted earnings per share from continuing operations was USD 0.04 compared to diluted loss per share from continuing operations of USD 0.89 a year ago.